Articles tagged "Kidney transplantation"

2020 American Transplant Congress
Improving Vaccination Rates for Influenza and Pneumococcal Disease in Pediatric Kidney Transplant Recipients
A. M. McGrath¹, J. Baquir¹, L. Maestretti¹, G. James¹, K. DiNello¹, M. Patton¹, A. Fong¹, A. Gallo², V. Sigurjonsdottir², P. Grimm², A. Chaudhuri²
¹Pediatric Kidney Transplant, Lucile Packard Children's Hospital Stanford, Palo Alto, CA, ²Pediatric Kidney Transplant, Stanford University, Palo Alto, CA
*Purpose: Pediatric renal transplant recipients are highly vulnerable to infections caused by influenza and pneumococcus and vaccines are recommended in this population. At our center,…
2020 American Transplant Congress
Multifaceted Roles of Follicular T Cell Subsets in Controlling Antibody Mediated Rejection
M. T. Mohammed
Renal- Transplant Research Center, Brigham and Women's Hospital- Harvard Medical School, Boston, MA
*Purpose: Assess the roles of T Follicular Helper and Regulatory cells in controlling pathogenic donor-specific antibodies (DSA) and antibody-mediated rejection(AbMR) during kidney transplantation.*Methods: Here we…
2020 American Transplant Congress
Under-Diagnosed Hyperoxalosis in Transplant-Listed Patients
A. Tariq, L. Lakhani, W. Greenspan, S. Alasfar, F. Naqvi, D. Brennan
Nephrology, Johns Hopkins University, Baltimore, MD
*Purpose: In an era of increasing kidney transplantation (KTx), hyperoxalosis remains an under-recognized cause for allograft failure. Bariatric interventions are significant risk factors for oxalosis,…
2020 American Transplant Congress
West Nile Virus Encephalitis in Kidney Transplant Recipients
F. Aziz, C. Saddler, M. Jorgenson, S. Parajuli, J. Smith, D. Mandelbrot
University of Wisconsin, Madison, WI
*Purpose: West Nile viral encephalitis is uncommon but can lead to permanent neurological damage. Transplant related West Nile viral disease has been described before; however,…
2020 American Transplant Congress
BK Viremia: A Double Edged Sword – The Impact of Immunosuppression Reduction on Allograft Rejection
A. Szczepanik¹, A. Bixby¹, C. Burrelli¹, A. Padiyar², T. Srinivas², K. Chavin³
¹Pharmacy, University Cleveland Medical Center, Cleveland, OH, ²Nephrology, University Cleveland Medical Center, Cleveland, OH, ³Surgery, University Cleveland Medical Center, Cleveland, OH
*Purpose: BK viremia (BKV) increases the risk of renal allograft loss following transplant. Guidelines recommend reduction of immunosuppression (IS) after BKV diagnosis, however, the ideal…
2020 American Transplant Congress
Perceived Barriers Are Associated with Immunosuppressive Medication Adherence among Japanese Kidney Transplant Recipients: A Cross-Sectional Study
M. Takada¹, K. Oda², T. Kaitani², M. Fujii²
¹The Graduate School of Nursing, Sapporo City University, Sapporo, Japan, ²School of Nursing, Sapporo City University, Sapporo, Japan
*Purpose: Nonadherence to immunosuppressive medication after kidney transplantation is associated with a high risk of acute rejection and allograft loss. This study aimed to investigate…
2020 American Transplant Congress
Characterization of an Integrative Prognostic Score for US Patients Taken from the DART Study
J. Bromberg¹, R. Bloom², P. Sood³
¹University of Maryland, Baltimore, MD, ²Penn Medicine, Philadelphia, PA, ³University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: iBox is a validated cloud-based software as a service (SaaS) algorithm that provides a predictive analysis of the post-transplant patient, quantifying the risk of…
2020 American Transplant Congress
The Time is Now: Improving Waiting Times in Minority Populations
L. Mendez-Castaner, L. Preczewski, M. Muldoon, A. Harshman, M. Goble, G. Guerra
Miami Transplant Institute, Miami, FL
*Purpose: A significant limiting factor to transplantation resides on waiting time based on blood type. Historically candidates in blood groups B and O experience higher…
2020 American Transplant Congress
Safety and Efficacy of Direct-Acting Oral Anticoagulants versus Warfarin in Kidney Transplant Recipients
A. L. Bixby¹, S. A. Shaikh², A. S. Naik³, L. Cotiguala³, K. McMurry³, M. D. Samaniego-Picota⁴, V. D. Marshall⁵, J. M. Park³
¹University Hospitals Cleveland Medical Center, Cleveland, OH, ²Keck Medical Center of USC, University of Southern California, Los Angeles, CA, ³Michigan Medicine, Ann Arbor, MI, ⁴Henry Ford Transplant Institute, Detroit, MI, ⁵University of Michigan College of Pharmacy, Ann Arbor, MI
*Purpose: Safety and efficacy of direct-acting oral anticoagulants (DOACs) have not been well studied in solid organ transplant. The purpose of our study was to…
2020 American Transplant Congress
Donor-Specific Antibody Test as a Screening Tool for Stable Long-Term Kidney Transplant Recipients
M. Mohamed¹, L. Hidalgo², S. Parajuli¹, N. Garg¹, F. Aziz¹, K. Swanson¹, E. Jochaim¹, D. Mandelbrot¹, A. Djamali¹, B. Astor¹
¹Department of Nephrology, Madison, WI, ²Department of Surgery, Madison, WI
*Purpose: Donor-specific antibody (DSA) is an established biomarker predicting antibody mediated rejection (AMR), but at substantial cost. The utility of DSA test as a screening…